新日股份(603787.SH)董事趙學忠擬減持不超20萬股
格隆匯2月17日丨新日股份(603787.SH)公佈,截至本公告披露日,公司股東、董事、總經理趙學忠持有公司股份1989萬股,佔公司股份總數的9.75%。上述股份均為無限售流通股且來源均為公司首次公開發行股票並上市前取得的股份。
因個人資金需求,趙學忠計劃自本公告披露之日起15個交易日後的6個月內,擬通過集中競價交易方式減持所持有的公司股份,減持數量不超過20萬股(含),佔公司股份總數的0.09804%,佔其持有的無限售流通股總數的1.00553%。減持價格將按照減持實施時的市場價格確定,且不低於發行價格。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.